New York Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 52 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 59,466
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 73.27%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 20,969
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 73.03%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 18.69% 21.02%
White, Hispanic/Latino Patients 10.89% 15.24%
Black/African American, Non-Hispanic/Latino Patients 13.03% 12.47%
Black/African American, Hispanic/Latino Patients 1.89% 1.90%
Asian Patients3 4.35% 5.10%
American Indian/Alaska Native Patients3 0.73% 0.95%
Native Hawaiian/Other Pacific Islander Patients3 0.65% 0.84%
Patients with More Than One Race3 3.66% 3.97%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 16.02% 16.45%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.73% 2.34%
Unreported/Refused to Report Race and Ethnicity 27.37% 19.73%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 9,851
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 89.69%
COVID-19 Immunization Series Completed 9,449
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 91.13%
COVID-19 Immunization Series Additional 15,610
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 84.41%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 7.79% 6.97% 12.77%
White, Hispanic/Latino Patients 8.77% 8.28% 7.80%
Black/African American, Non-Hispanic/Latino Patients 20.56% 21.66% 15.04%
Black/African American, Hispanic/Latino Patients 3.63% 3.58% 2.62%
Asian Patients3 3.71% 5.97% 15.84%
American Indian/Alaska Native Patients3 1.21% 0.87% 3.20%
Native Hawaiian/Other Pacific Islander Patients3 0.67% 1.01% 0.48%
Patients with More Than One Race3 6.97% 10.06% 4.66%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 22.20% 20.21% 19.49%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.75% 4.17% 5.30%
Unreported/Refused to Report Race and Ethnicity 20.75% 17.22% 12.79%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 13.46%
1 to 24 Hours 11.54%
More Than 24 Hours 73.08%
N/A 1.92%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 9.62%
Staffing to administer the vaccine 48.08%
Vaccine confidence 34.62%
Vaccine storage capacity 0.00%
Vaccine supply 1.92%
Other 0.00%
None 26.92%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 21.15%
Average Percent of Health Center Visits Conducted Virtually 19.04%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 34.62%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 27
Number of School-Based Vaccination Sites 11
Number of Family Vaccination Clinics 76

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 7.69%
Refer patients to another organization that provides monoclonal antibody therapies 42.31%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.77%
Patient awareness/education 5.77%
Staffing capacity 21.15%
Therapy administration/onsite logistics 25.00%
Other 3.85%
None 50.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 26
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 82,035

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 84.62%
Provide to General Public Who Came to the Health Center 53.85%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 23.08%
Provide at Other Community Events 30.77%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 34.62%
Other 30.77%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 4
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 61.54%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 30.77%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 38.46%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 7.69%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 15.38%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 30.77%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022